Diabetic Medicine

SJR Rank #3,165H-index: 177SJR: 1.297Best quartile: Q1APC: US$4,870
Journal website: aims, scope and author guidelines
Publisher

Wiley-Blackwell Publishing Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • Endocrinology, Diabetes and MetabolismQ1
  • Internal MedicineQ1
  • EndocrinologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Diabetes Management and ResearchDiabetes Management and EducationDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes and associated disordersDiabetes Treatment and ManagementPancreatic function and diabetesHyperglycemia and glycemic control in critically ill and hospitalized patientsGestational Diabetes Research and ManagementMetabolism, Diabetes, and CancerDiabetic Foot Ulcer Assessment and Management

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025065130195260

Detailed Information

ISSN

1464-5491, 0742-3071

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.09

References per Document

35.17

Coverage

1984-2026

Scope

Diabetic Medicine, the official journal of Diabetes UK, is published monthly simultaneously, in print and online editions. The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed. We aim to disseminate knowledge about diabetes research with the goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all healthcare professionals working with people with diabetes, whether in primary care or specialist services. Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.”

Metrics from SCImago Journal Rank 2025. View on SCImago